Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Centaury herb (*Centaurii herba*) is a traditional herbal preparation derived from the dried, flowering aerial parts of the common centaury plant (*Centaurium erythraea*). It contains active phytochemicals such as flavonoids, xanthone derivatives, and secoiridoid bitter glycosides (including swertiamarin, gentiopicroside, and sweroside). Traditionally used in European herbal medicine as a bitter tonic to stimulate appetite and treat dyspeptic or gastrointestinal complaints, centaury herb has no established therapeutic efficacy against malaria. In a Phase 1 clinical trial conducted by the Centre de Recherche Médicale de Lambaréné (CERMEL) in Gabon, an infusion of centaury herb was utilized strictly as an inert, inactive placebo comparator to evaluate the safety and efficacy of an *Artemisia annua* infusion for treating asymptomatic *Plasmodium falciparum* infection in semi-immune adults.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on centaury herb.